Prevalence and Factors Associated with Olfactory Dysfunction in Individuals with COVID-19 in Brazil: A Study of 20,669 Cases from 2020 to 2021

Abstract Objective: The aim of the study is to determine the prevalence and factors associated with olfactory dysfunction in individuals with COVID-19 in the first 2 years of the pandemic in Brazil. Materials and Methods: This is a prevalent study involving the confirmed cases of COVID-19 recorded i...

Full description

Saved in:
Bibliographic Details
Published inMedical principles and practice Vol. 33; no. 2; pp. 164 - 172
Main Authors Souza, Carlos Dornels Freire de, Magalhães, Amanda Júlia de Arruda, Silva Nobre, Yasmin Vitória, Souza, Carlos Alberto, Nascimento, André Luis Oliveira do, Faria, Luísa Robalinho de, Bezerra-Santos, Márcio, Armstrong, Anderson da Costa, Nicácio, Jandir Mendonça, Gomes, Orlando Vieira, Carmo, Rodrigo Feliciano do
Format Journal Article
LanguageEnglish
Published Basel, Switzerland S. Karger AG 01.04.2024
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Abstract Objective: The aim of the study is to determine the prevalence and factors associated with olfactory dysfunction in individuals with COVID-19 in the first 2 years of the pandemic in Brazil. Materials and Methods: This is a prevalent study involving the confirmed cases of COVID-19 recorded in the municipality between the years 2020 and 2021. Individuals symptomatic for COVID-19, with a positive laboratory result and aged 12 or older were included in this study. Measures of central tendency and dispersion were used in the description of continuous variables and frequency was used for categorical variables. The Shapiro-Wilk test was used to evaluate data distribution. Results: Data from 20,669 individuals were analyzed. The prevalence of olfactory disorders was 17.9% and increased from 11.5% to 21.9% between 2020 and 2021. A female gender predominance was observed among individuals who reported anosmia, with 61.1% (n = 564) in 2020 and 61.7% (n = 1,713) in 2021. On the other hand, the median age of individuals with olfactory disorders was lower than that of the group without disorders (35 [IQR 27–46] vs. 39 [IQR 29–50]; p < 0.001). Smell disturbances were present in 18.2% (n = 3,634) of patients who recovered and in 7.1% (n = 38) of those who died. Furthermore, in 2021, a prevalence rate of 30.6% for olfactory disorders was linked to obesity as a comorbidity. Conclusion: The prevalence of olfactory disorders was lower compared to other studies, with cough and fever being negatively related to olfactory dysfunction and headache, coryza, and taste disorders being positively related. Obesity was the only associated comorbidity. Highlights of the StudyThe prevalence of olfactory disorders was 17.9% and increased from 11.5% to 21.9% between 2020 and 2021.Headache (odds ratio [OR] 1.32 and 1.22, respectively), coryza (OR 3.51 and 1.22, respectively), and taste disorders (OR 159.13 and 96.86, respectively) were associated with the presence of olfactory dysfunction.
AbstractList The aim of the study is to determine the prevalence and factors associated with olfactory dysfunction in individuals with COVID-19 in the first 2 years of the pandemic in Brazil. This is a prevalent study involving the confirmed cases of COVID-19 recorded in the municipality between the years 2020 and 2021. Individuals symptomatic for COVID-19, with a positive laboratory result and aged 12 or older were included in this study. Measures of central tendency and dispersion were used in the description of continuous variables and frequency was used for categorical variables. The Shapiro-Wilk test was used to evaluate data distribution. Data from 20,669 individuals were analyzed. The prevalence of olfactory disorders was 17.9% and increased from 11.5% to 21.9% between 2020 and 2021. A female gender predominance was observed among individuals who reported anosmia, with 61.1% (n = 564) in 2020 and 61.7% (n = 1,713) in 2021. On the other hand, the median age of individuals with olfactory disorders was lower than that of the group without disorders (35 [IQR 27-46] vs. 39 [IQR 29-50]; p < 0.001). Smell disturbances were present in 18.2% (n = 3,634) of patients who recovered and in 7.1% (n = 38) of those who died. Furthermore, in 2021, a prevalence rate of 30.6% for olfactory disorders was linked to obesity as a comorbidity. The prevalence of olfactory disorders was lower compared to other studies, with cough and fever being negatively related to olfactory dysfunction and headache, coryza, and taste disorders being positively related. Obesity was the only associated comorbidity.
Abstract Objective: The aim of the study is to determine the prevalence and factors associated with olfactory dysfunction in individuals with COVID-19 in the first 2 years of the pandemic in Brazil. Materials and Methods: This is a prevalent study involving the confirmed cases of COVID-19 recorded in the municipality between the years 2020 and 2021. Individuals symptomatic for COVID-19, with a positive laboratory result and aged 12 or older were included in this study. Measures of central tendency and dispersion were used in the description of continuous variables and frequency was used for categorical variables. The Shapiro-Wilk test was used to evaluate data distribution. Results: Data from 20,669 individuals were analyzed. The prevalence of olfactory disorders was 17.9% and increased from 11.5% to 21.9% between 2020 and 2021. A female gender predominance was observed among individuals who reported anosmia, with 61.1% (n = 564) in 2020 and 61.7% (n = 1,713) in 2021. On the other hand, the median age of individuals with olfactory disorders was lower than that of the group without disorders (35 [IQR 27–46] vs. 39 [IQR 29–50]; p < 0.001). Smell disturbances were present in 18.2% (n = 3,634) of patients who recovered and in 7.1% (n = 38) of those who died. Furthermore, in 2021, a prevalence rate of 30.6% for olfactory disorders was linked to obesity as a comorbidity. Conclusion: The prevalence of olfactory disorders was lower compared to other studies, with cough and fever being negatively related to olfactory dysfunction and headache, coryza, and taste disorders being positively related. Obesity was the only associated comorbidity. Highlights of the StudyThe prevalence of olfactory disorders was 17.9% and increased from 11.5% to 21.9% between 2020 and 2021.Headache (odds ratio [OR] 1.32 and 1.22, respectively), coryza (OR 3.51 and 1.22, respectively), and taste disorders (OR 159.13 and 96.86, respectively) were associated with the presence of olfactory dysfunction.
The aim of the study is to determine the prevalence and factors associated with olfactory dysfunction in individuals with COVID-19 in the first 2 years of the pandemic in Brazil.OBJECTIVEThe aim of the study is to determine the prevalence and factors associated with olfactory dysfunction in individuals with COVID-19 in the first 2 years of the pandemic in Brazil.This is a prevalent study involving the confirmed cases of COVID-19 recorded in the municipality between the years 2020 and 2021. Individuals symptomatic for COVID-19, with a positive laboratory result and aged 12 or older were included in this study. Measures of central tendency and dispersion were used in the description of continuous variables and frequency was used for categorical variables. The Shapiro-Wilk test was used to evaluate data distribution.MATERIALS AND METHODSThis is a prevalent study involving the confirmed cases of COVID-19 recorded in the municipality between the years 2020 and 2021. Individuals symptomatic for COVID-19, with a positive laboratory result and aged 12 or older were included in this study. Measures of central tendency and dispersion were used in the description of continuous variables and frequency was used for categorical variables. The Shapiro-Wilk test was used to evaluate data distribution.Data from 20,669 individuals were analyzed. The prevalence of olfactory disorders was 17.9% and increased from 11.5% to 21.9% between 2020 and 2021. A female gender predominance was observed among individuals who reported anosmia, with 61.1% (n = 564) in 2020 and 61.7% (n = 1,713) in 2021. On the other hand, the median age of individuals with olfactory disorders was lower than that of the group without disorders (35 [IQR 27-46] vs. 39 [IQR 29-50]; p < 0.001). Smell disturbances were present in 18.2% (n = 3,634) of patients who recovered and in 7.1% (n = 38) of those who died. Furthermore, in 2021, a prevalence rate of 30.6% for olfactory disorders was linked to obesity as a comorbidity.RESULTSData from 20,669 individuals were analyzed. The prevalence of olfactory disorders was 17.9% and increased from 11.5% to 21.9% between 2020 and 2021. A female gender predominance was observed among individuals who reported anosmia, with 61.1% (n = 564) in 2020 and 61.7% (n = 1,713) in 2021. On the other hand, the median age of individuals with olfactory disorders was lower than that of the group without disorders (35 [IQR 27-46] vs. 39 [IQR 29-50]; p < 0.001). Smell disturbances were present in 18.2% (n = 3,634) of patients who recovered and in 7.1% (n = 38) of those who died. Furthermore, in 2021, a prevalence rate of 30.6% for olfactory disorders was linked to obesity as a comorbidity.The prevalence of olfactory disorders was lower compared to other studies, with cough and fever being negatively related to olfactory dysfunction and headache, coryza, and taste disorders being positively related. Obesity was the only associated comorbidity.CONCLUSIONThe prevalence of olfactory disorders was lower compared to other studies, with cough and fever being negatively related to olfactory dysfunction and headache, coryza, and taste disorders being positively related. Obesity was the only associated comorbidity.
Objective: The aim of the study is to determine the prevalence and factors associated with olfactory dysfunction in individuals with COVID-19 in the first 2 years of the pandemic in Brazil. Materials and Methods: This is a prevalent study involving the confirmed cases of COVID-19 recorded in the municipality between the years 2020 and 2021. Individuals symptomatic for COVID-19, with a positive laboratory result and aged 12 or older were included in this study. Measures of central tendency and dispersion were used in the description of continuous variables and frequency was used for categorical variables. The Shapiro-Wilk test was used to evaluate data distribution. Results: Data from 20,669 individuals were analyzed. The prevalence of olfactory disorders was 17.9% and increased from 11.5% to 21.9% between 2020 and 2021. A female gender predominance was observed among individuals who reported anosmia, with 61.1% (n = 564) in 2020 and 61.7% (n = 1,713) in 2021. On the other hand, the median age of individuals with olfactory disorders was lower than that of the group without disorders (35 [IQR 27–46] vs. 39 [IQR 29–50]; p < 0.001). Smell disturbances were present in 18.2% (n = 3,634) of patients who recovered and in 7.1% (n = 38) of those who died. Furthermore, in 2021, a prevalence rate of 30.6% for olfactory disorders was linked to obesity as a comorbidity. Conclusion: The prevalence of olfactory disorders was lower compared to other studies, with cough and fever being negatively related to olfactory dysfunction and headache, coryza, and taste disorders being positively related. Obesity was the only associated comorbidity.
Introduction On December 31, 2019, China reported cases of pneumonia of unknown etiology to the World Health Organization (WHO) [1]. [...]evidence indicates that olfactory changes can serve as a marker for disease at the onset of SARS-CoV-2 infection, providing valuable information for recommending isolation even before obtaining RT-PCR test results. Affected individuals may be exposed to hazardous substances, such as gases, smoke, and spoiled food, without being aware of it [16]. [...]depressive and anxiety disorders are associated with the reduced quality of life for affected individuals. Among individuals who reported anosmia, there was a higher proportion of females, with 61.1% (n = 564) in 2020 and 61.7% (n = 1,713) in 2021.
Author Armstrong, Anderson da Costa
Bezerra-Santos, Márcio
Souza, Carlos Alberto
Gomes, Orlando Vieira
Carmo, Rodrigo Feliciano do
Nascimento, André Luis Oliveira do
Faria, Luísa Robalinho de
Silva Nobre, Yasmin Vitória
Souza, Carlos Dornels Freire de
Nicácio, Jandir Mendonça
Magalhães, Amanda Júlia de Arruda
Author_xml – sequence: 1
  givenname: Carlos Dornels Freire de
  surname: Souza
  fullname: Souza, Carlos Dornels Freire de
  email: *Carlos Dornels Freire de Souza, carlos.dornels@univasf.edu.br
– sequence: 2
  givenname: Amanda Júlia de Arruda
  surname: Magalhães
  fullname: Magalhães, Amanda Júlia de Arruda
– sequence: 3
  givenname: Yasmin Vitória
  surname: Silva Nobre
  fullname: Silva Nobre, Yasmin Vitória
– sequence: 4
  givenname: Carlos Alberto
  surname: Souza
  fullname: Souza, Carlos Alberto
  email: *Carlos Dornels Freire de Souza, carlos.dornels@univasf.edu.br
– sequence: 5
  givenname: André Luis Oliveira do
  surname: Nascimento
  fullname: Nascimento, André Luis Oliveira do
– sequence: 6
  givenname: Luísa Robalinho de
  surname: Faria
  fullname: Faria, Luísa Robalinho de
– sequence: 7
  givenname: Márcio
  surname: Bezerra-Santos
  fullname: Bezerra-Santos, Márcio
– sequence: 8
  givenname: Anderson da Costa
  surname: Armstrong
  fullname: Armstrong, Anderson da Costa
– sequence: 9
  givenname: Jandir Mendonça
  surname: Nicácio
  fullname: Nicácio, Jandir Mendonça
– sequence: 10
  givenname: Orlando Vieira
  surname: Gomes
  fullname: Gomes, Orlando Vieira
– sequence: 11
  givenname: Rodrigo Feliciano do
  surname: Carmo
  fullname: Carmo, Rodrigo Feliciano do
BackLink https://www.ncbi.nlm.nih.gov/pubmed/38198785$$D View this record in MEDLINE/PubMed
BookMark eNpt0luPEyEUB3Bi1rgXffDdGBJfNHGUM8wwgy-mdl1tsqZNvLwShssu6xQqzNTUD-FnltpaL5EXCOeXP4fAKTrywRuE7gN5BlDz54SQmjLgcAudQFXSgkANR3lNAIqmbuAYnaZ0k1lLKbmDjmkLvG3a-gR9X0Szlr3xymDpNb6Qaggx4UlKQTk5GI2_uuEaz3v7s7LB55tkR68GFzx2Hs-8dmunR9mnnZzOP83OC-Db4qsov7n-BZ7g98OoNzhYXJKnjHE8lckkbGNY5p2S4CFsZ7iLbtucZO7t5zP08eL1h-nb4nL-ZjadXBaqaslQWE0J2LKqbMeMqnljeVdSzbqWdIRToksDLQWlqKnrjnWWAQPTVR01hDSK0jP0cpe7Grul0cr4IcperKJbyrgRQTrxd8W7a3EV1gKAcNZwyAmP9wkxfBlNGsTSJWX6XnoTxiTKbKo8Wp7po3_oTRijz_cTlFSsausSqqwe_tnSoZdfb5XBkx1QMaQUjT0QIGL7D8ThH_w-8rOMVyYe5LvFYifEStusHvxX7UN-AA2ztmU
Cites_doi 10.1016/j.bjorl.2021.04.001
10.4178/epih.e2023079
10.1111/odi.13951
10.3346/jkms.2020.35.e174
10.1111/obr.12800
10.1093/ve/veac024
10.1007/s13365-022-01060-9
10.1136/bmj-2021-069503
10.1007/s00405-020-05965-1
10.1007/s12070-021-02630-9
10.1007/s00405-021-06826-1
10.1021/acschemneuro.1c00542
10.12688/f1000research.28393.1
10.3389/fimmu.2023.1045009
10.1152/physrev.00012.2023
10.1590/1806-9282.20220078
10.36660/abc.20200209
10.1016/j.tins.2022.11.003
10.1007/s00508-020-01760-4
10.1007/s00415-010-5513-8
http://doi.org/10.1056/NEJMoa2001017
10.1016/j.cmi.2020.12.029
10.1016/j.bjorl.2020.05.008
10.1016/j.virusres.2021.198532
10.1016/j.amjoto.2020.102581
10.1016/j.bjorl.2020.12.002
10.1093/ofid/ofaa199
10.1038/s41588-021-00986-w
10.1016/j.cell.2020.06.043
10.1007/s00405-020-06496-5
10.1038/s41598-021-92775-y
10.1371/journal.pone.0256998
10.1177/0194599820925056
10.1055/s-0042-1758716
http://doi.org/10.1136/jnnp-2022-329162
10.1038/s41586-020-2012-7
10.1017/S0950268821000935
10.3389/fphys.2021.622987
10.1016/j.bjorl.2020.08.001
10.1177/0194599820965920
10.1016/j.jadr.2021.100156
10.3390/nu14061262
ContentType Journal Article
Copyright 2024 The Author(s). Published by S. Karger AG, Basel
2024 The Author(s). Published by S. Karger AG, Basel.
2024 The Author(s). Published by S. Karger AG, Basel. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at: https://uk.sagepub.com/en-gb/eur/reusing-open-access-and-sage-choice-content
2024 The Author(s). Published by S. Karger AG, Basel 2024
Copyright_xml – notice: 2024 The Author(s). Published by S. Karger AG, Basel
– notice: 2024 The Author(s). Published by S. Karger AG, Basel.
– notice: 2024 The Author(s). Published by S. Karger AG, Basel. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at: https://uk.sagepub.com/en-gb/eur/reusing-open-access-and-sage-choice-content
– notice: 2024 The Author(s). Published by S. Karger AG, Basel 2024
DBID M--
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
BENPR
CCPQU
FYUFA
GHDGH
K9.
M0S
M1P
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOI 10.1159/000536191
DatabaseName Karger Open Access Journals
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
ProQuest - Health & Medical Complete保健、医学与药学数据库
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central
ProQuest Central UK/Ireland
ProQuest Central
ProQuest One Community College
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
Medical Database
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Central China
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
Health Research Premium Collection
ProQuest Medical Library
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
Health & Medical Research Collection
ProQuest Central (New)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Medical Library (Alumni)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE

MEDLINE - Academic
CrossRef
ProQuest One Academic Middle East (New)
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: M--
  name: Karger Open Access Journals
  url: https://www.karger.com/OpenAccess
  sourceTypes:
    Enrichment Source
    Publisher
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitleAlternate Olfactory Dysfunction in Individuals with COVID-19 in Brazil
EISSN 1423-0151
EndPage 172
ExternalDocumentID PMC11096791
38198785
10_1159_000536191
536191
Genre Journal Article
GeographicLocations Brazil
GeographicLocations_xml – name: Brazil
GroupedDBID ---
0R~
0~B
30W
326
36B
3O.
3V.
4.4
53G
5GY
7X7
88E
8FI
8FJ
8UI
AAWTL
AAYIC
ABPAZ
ABUWG
ACGFS
ADBBV
AENEX
AEYAO
AFKRA
AHMBA
ALDHI
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZPMC
BAWUL
BCNDV
BENPR
BPHCQ
BVXVI
CCPQU
CS3
CYUIP
DU5
E0A
E3Z
EBS
EMB
EMOBN
F5P
FB.
FYUFA
GROUPED_DOAJ
HMCUK
HYE
HZ~
IAO
IHR
KUZGX
M--
M1P
MK0
O1H
O9-
OK1
P2P
PQQKQ
PROAC
PSQYO
RKO
RNS
RPM
SV3
UJ6
UKHRP
AAYXX
ABBTS
ABWCG
ACQXL
ADAGL
AFJJK
AFSIO
AHFRZ
AIOBO
CAG
CITATION
COF
DIK
EJD
ITC
PHGZM
PHGZT
RIG
RXVBD
TR2
CGR
CUY
CVF
ECM
EIF
NPM
7XB
8FK
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQUKI
PRINS
7X8
5PM
ID FETCH-LOGICAL-c480t-fd301f244fb6ec597f9b23d6b80b0930d2e1831cc3e55b6bf6161eb4b3e007c33
IEDL.DBID 7X7
ISSN 1011-7571
1423-0151
IngestDate Thu Aug 21 18:35:34 EDT 2025
Thu Jul 10 18:32:36 EDT 2025
Fri Jul 25 06:48:55 EDT 2025
Sat May 10 01:40:50 EDT 2025
Tue Jul 01 05:09:30 EDT 2025
Thu Aug 29 12:04:27 EDT 2024
Sat Aug 31 21:00:32 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords COVID-19
SARS-CoV-2
Symptoms
Smell
Language English
License This article is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC). Usage and distribution for commercial purposes requires written permission.
https://creativecommons.org/licenses/by-nc/4.0
2024 The Author(s). Published by S. Karger AG, Basel.
This article is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC) (http://www.karger.com/Services/OpenAccessLicense). Usage and distribution for commercial purposes requires written permission.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c480t-fd301f244fb6ec597f9b23d6b80b0930d2e1831cc3e55b6bf6161eb4b3e007c33
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink https://karger.com/doi/10.1159/000536191
PMID 38198785
PQID 3046485214
PQPubID 2047984
PageCount 9
ParticipantIDs pubmed_primary_38198785
proquest_journals_3046485214
proquest_miscellaneous_2913444489
crossref_primary_10_1159_000536191
pubmedcentral_primary_oai_pubmedcentral_nih_gov_11096791
karger_primary_536191
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2024-04-01
PublicationDateYYYYMMDD 2024-04-01
PublicationDate_xml – month: 04
  year: 2024
  text: 2024-04-01
  day: 01
PublicationDecade 2020
PublicationPlace Basel, Switzerland
PublicationPlace_xml – name: Basel, Switzerland
– name: Switzerland
– name: Basel
PublicationTitle Medical principles and practice
PublicationTitleAlternate Med Princ Pract
PublicationYear 2024
Publisher S. Karger AG
Publisher_xml – name: S. Karger AG
References Hojo-Souza NS, Freitas VLS, Guidoni DL, Souza FSH. Clinical symptom profile of hospitalized COVID-19 Brazilian patients according to SARS-CoV-2 variants. Epidemiol Health. 2023;45:e2023079–2023. .
Velluzzi F, Deledda A, Onida M, Loviselli A, Crnjar R, Sollai G. Relationship between olfactory function and BMI in normal weight healthy subjects and patients with overweight or obesity. Nutrients. 2022;14(6):1262. .
Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, . A novel Coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727–33. .
Chen S, Wang S. The immune mechanism of the nasal epithelium in COVID-19-related olfactory dysfunction. Front Immunol. 2023;14:1045009. .
Shelton JF, Shastri AJ, Fletez-Brant K, Aslibekyan S, Auton A; 23andMe COVID-19 Team. The UGT2A1/UGT2A2 locus is associated with COVID-19-related loss of smell or taste. Nat Genet. 2022;54(2):121–4. .
Ahmed AK, Sayad R, Mahmoud IA, EL-Monem AMA, Badry SH, Ibrahim IH, . “Anosmia” the mysterious collateral damage of COVID-19. J Neurovirol. 2022;28(2):189–200. .
Lechien JR, Chiesa-Estomba CM, De Siati DR, Horoi M, Le Bon SD, . Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Oto-Rhino-Laryngol. 2020;277(8):2251–61. .
Gamerra M, de Corso E, Cantone E. COVID-19: the crucial role of the nose. Braz J Otorhinolaryngol. 2021;87(1):118–9. .
von Bartheld CS, Hagen MM, Butowt R. The D614G virus mutation enhances anosmia in COVID-19 patients: evidence from a systematic review and meta-analysis of studies from South Asia. ACS Chem Neurosci. 2021;12(19):3535–49. .
Terças-Trettel ACP, Muraro AP, Andrade ACd S, Oliveira EC. Self-reported symptoms and seroprevalence against SARS-CoV-2 in the population of Mato Grosso: a household-based survey in 2020. Rev Assoc Med Bras. 2022;68(7):928–34. .
Zhou P, Yang X-L, Wang X-G, Hu B, Zhang L, Zhang W, . A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579(7798):270–3. .
Lima MHLC, Cavalcante ALB, Leão SC. Pathophysiological relationship between COVID-19 and olfactory dysfunction: a systematic review. Braz J Otorhinolaryngol. 2021. .
Vestito L, Mori L, Trompetto C, Bagnasco D, Canevari RF, Ponzano M, . Impact of tDCS on persistent COVID-19 olfactory dysfunction: a double-blind sham-controlled study. J Neurol Neurosurg Psychiatry. 2023;94(1):87–8. .
Meng X, Deng Y, Dai Z, Meng Z. COVID-19 and anosmia: a review based on up-to-date knowledge. Am J Otolaryngol. 2020;41(5):102581. .
Costa KVTda, Carnaúba ATL, Rocha KW, Andrade KCLde, Ferreira SMS, Menezes Pd L. Olfactory and taste disorders in COVID-19: a systematic review. Braz J Otorhinolaryngol. 2020;86(6):781–92. .
Burges Watson DL, Campbell M, Hopkins C, Smith B, Kelly C, Deary V. Altered smell and taste: anosmia, parosmia and the impact of long Covid-19. PLoS One. 2021;16(9):e0256998. .
Giovanetti M, Fonseca V, Wilkinson E, Tegally H, San EJ, Althaus CL, . Replacement of the Gamma by the Delta variant in Brazil: impact of lineage displacement on the ongoing pandemic. Virus Evol. 2022;8(1):veac024–6. .
Silva FTD, Sperandio M, Suzuki SS, Silva HPV, de Oliveira DG, Stefenon L, . Self-reported taste and smell impairment among patients diagnosed with COVID-19 in Brazil. Oral Dis. 2022;28(Suppl 2):2559–62. .
Feehan AK, Fort D, Velasco C, Burton JH, Garcia-Diaz J, Price-Haywood EG, . The importance of anosmia, ageusia and age in community presentation of symptomatic and asymptomatic SARS-CoV-2 infection in Louisiana, USA; a cross-sectional prevalence study. Clin Microbiol Infect. 2021;27(4):633.e9–16. .
Yom-Tov E, Lekkas D, Jacobson NC. Association of COVID19-induced anosmia and ageusia with depression and suicidal ideation. J Affect Disord. 2021;5:100156. .
Altundag A, Saatci O, Sanli DET, Duz OA, Sanli AN, Olmuscelik O, . The temporal course of COVID-19 anosmia and relation to other clinical symptoms. Eur Arch Oto-Rhino-Laryngol. 2021;278(6):1891–7. .
Franceschi VB, Ferrareze PAG, Zimerman RA, Cybis GB, Thompson CE. Mutation hotspots and spatiotemporal distribution of SARS-CoV-2 lineages in Brazil, February 2020-2021. Virus Res. 2021;304:198532. .
Strabelli TMV, Uip DE. COVID-19 and the heart. Arq Bras Cardiol. 2020;114(4):598–600. .
Mutiawati E, Fahriani M, Mamada SS, Fajar JK, Frediansyah A, Maliga HA, . Anosmia and dysgeusia in SARS-CoV-2 infection: incidence and effects on COVID-19 severity and mortality, and the possible pathobiology mechanisms - a systematic review and meta-analysis. F1000Res. 2021;10:40. .
Tan BKJ, Han R, Zhao JJ, Tan NKW, Quah ESH, Tan CJ, . Prognosis and persistence of smell and taste dysfunction in patients with covid-19: meta-analysis with parametric cure modelling of recovery curves. BMJ. 2022;378:e069503. .
Peng M, Coutts D, Wang T, Cakmak YO. Systematic review of olfactory shifts related to obesity. Obes Rev. 2019;20(2):325–38. .
Korber B, Fischer WM, Gnanakaran S, Yoon H, Theiler J, Abfalterer W, . Tracking changes in SARS-CoV-2 spike: evidence that D614G increases infectivity of the COVID-19 virus. Cell. 2020;182(4):812–27.e19. .
Hendawy E, El-Anwar MW, Elghamry RM, Abdallah AM, Ibrahim AM. Anosmia in COVID-19 patients: can we predict the severity of chest manifestations. Int Arch Otorhinolaryngol. 2023;27(1):e143–1. .
Tsukahara T, Brann DH, Datta SR. Mechanisms of SARS-CoV-2-associated anosmia. Physiol Rev. 2023;103(4):2759–66. .
Mendonça CV, Mendes Neto JA, Suzuki FA, Orth MS, Machado Neto H, Nacif SR. Disfunção de olfato na Covid-19: marcador de bom prognóstico. Braz J Otorhinolaryngol. 2022;88(3):439–44. .
Instituto Brasileiro de Geografia e Estatística. Dados demográficos. Bahia. 2023. Available from: https://www.ibge.gov.br/cidades-e-estados/ba.html.
Karimi-Galougahi M, Raad N, Mikaniki N. Anosmia and the need for COVID-19 screening during the pandemic. Otolaryngol Head Neck Surg. 2020;163(1):96–97. .
Mutiawati E, Fahriani M, Mamada SS, Fajar JK, Frediansyah A, Maliga HA, . Anosmia and dysgeusia in SARS-CoV-2 infection: incidence and effects on COVID-19 severity and mortality, and the possible pathobiology mechanisms: a systematic review and meta-analysis. F1000Res. 2021;10:40.
Lee Y, Min P, Lee S, Kim S-W. Prevalence and duration of Acute loss of smell or taste in COVID-19 patients. J Korean Med Sci. 2020;35(18):e174. .
Rashid RA, Alaqeedy AA, Al-Ani RM. Parosmia due to COVID-19 disease: a 268 case series. Indian J Otolaryngol Head Neck Surg. 2021;74(Suppl 2):2970–7. .
Chung TW, Sridhar S, Zhang AJ, Chan KH, Li HL, Wong FK, . Olfactory dysfunction in Coronavirus disease 2019 patients: observational cohort study and systematic review. Open Forum Infect Dis. 2020;7(6):ofaa199. .
Altundag A, Yıldırım D, Tekcan Sanli DE, Cayonu M, Kandemirli SG, Sanli AN, . Olfactory cleft measurements and COVID-19–related anosmia. Otolaryngol Head Neck Surg. 2021;164(6):1337–44. .
Butowt R, Bilinska K, von Bartheld CS. Olfactory dysfunction in COVID-19: new insights into the underlying mechanisms. Trends Neurosci. 2023;46(1):75–90. .
Prem B, Liu DT, Besser G, Renner B, Mueller CA. Retronasal olfactory testing in early diagnosed and suspected COVID-19 patients: a 7-week follow-up study. Eur Arch Oto-Rhino-Laryngol. 2022;279(1):257–65. .
Menezes AMB, Victora CG, Hartwig FP, Silveira MF, Horta BL, Barros AJD, . High prevalence of symptoms among Brazilian subjects with antibodies against SARS-CoV-2. Sci Rep. 2021;11(1):13279. .
Landis BN, Scheibe M, Weber C, Berger R, Brämerson A, Bende M, . Chemosensory interaction: acquired olfactory impairment is associated with decreased taste function. J Neurol. 2010;257(8):1303–8. .
Baggio JAO, Machado MF, do CRF, Armstrong Ada C, Santos ADdos, Souza CDFde. COVID-19 in Brazil: spatial risk, social vulnerability, human development, clinical manifestations and predictors of mortality–a retrospective study with data from 59,695 individuals. Epidemiol Infect. 2021:149. .
World Health Organization (WHO). Coronavirus disease 2019 (COVID-19): situation report - 51. Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200311-sitrep-51-covid-19.pdf?sfvrsn=1ba62e57_10 (accessed Sep 10, 2022).
Sbrana MF, Fornazieri MA, Bruni-Cardoso A, Avelino-Silva VI, Schechtman D, Voegels RL, . Olfactory dysfunction in frontline health care professionals during COVID-19 pandemic in Brazil. Front Physiol. 2021;12:622987. .
Secretaria de Saúde (Bahia). Núcleos Regionais de Saúde: regiões de Saúde do Estado da Bahia. 2022. Available from: http://www1.saude.ba.gov.br/mapa_bahia/VISAOMACRORREGIAOch.asp.
Mesquita RR, Silva LCF, Santana FMS, Oliveira TF, Alcântara RC, Arnozo G, . Clinical manifestations of COVID-19 in the general population: systematic review. Wien Klin Wochenschr. 2020;133(7-8):377–382. .
ref13
ref35
ref12
ref34
ref15
ref37
ref14
ref36
ref31
ref30
ref11
ref33
ref10
ref32
ref2
ref1
ref17
ref39
ref16
ref38
ref19
ref18
ref24
ref23
ref26
ref25
ref20
ref42
ref41
ref22
ref21
ref43
ref28
ref27
ref29
ref8
ref7
ref9
ref4
ref3
ref6
ref5
ref40
References_xml – reference: Peng M, Coutts D, Wang T, Cakmak YO. Systematic review of olfactory shifts related to obesity. Obes Rev. 2019;20(2):325–38. .
– reference: Secretaria de Saúde (Bahia). Núcleos Regionais de Saúde: regiões de Saúde do Estado da Bahia. 2022. Available from: http://www1.saude.ba.gov.br/mapa_bahia/VISAOMACRORREGIAOch.asp.
– reference: Franceschi VB, Ferrareze PAG, Zimerman RA, Cybis GB, Thompson CE. Mutation hotspots and spatiotemporal distribution of SARS-CoV-2 lineages in Brazil, February 2020-2021. Virus Res. 2021;304:198532. .
– reference: Butowt R, Bilinska K, von Bartheld CS. Olfactory dysfunction in COVID-19: new insights into the underlying mechanisms. Trends Neurosci. 2023;46(1):75–90. .
– reference: Costa KVTda, Carnaúba ATL, Rocha KW, Andrade KCLde, Ferreira SMS, Menezes Pd L. Olfactory and taste disorders in COVID-19: a systematic review. Braz J Otorhinolaryngol. 2020;86(6):781–92. .
– reference: Menezes AMB, Victora CG, Hartwig FP, Silveira MF, Horta BL, Barros AJD, . High prevalence of symptoms among Brazilian subjects with antibodies against SARS-CoV-2. Sci Rep. 2021;11(1):13279. .
– reference: Lechien JR, Chiesa-Estomba CM, De Siati DR, Horoi M, Le Bon SD, . Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Oto-Rhino-Laryngol. 2020;277(8):2251–61. .
– reference: Yom-Tov E, Lekkas D, Jacobson NC. Association of COVID19-induced anosmia and ageusia with depression and suicidal ideation. J Affect Disord. 2021;5:100156. .
– reference: von Bartheld CS, Hagen MM, Butowt R. The D614G virus mutation enhances anosmia in COVID-19 patients: evidence from a systematic review and meta-analysis of studies from South Asia. ACS Chem Neurosci. 2021;12(19):3535–49. .
– reference: Hendawy E, El-Anwar MW, Elghamry RM, Abdallah AM, Ibrahim AM. Anosmia in COVID-19 patients: can we predict the severity of chest manifestations. Int Arch Otorhinolaryngol. 2023;27(1):e143–1. .
– reference: Rashid RA, Alaqeedy AA, Al-Ani RM. Parosmia due to COVID-19 disease: a 268 case series. Indian J Otolaryngol Head Neck Surg. 2021;74(Suppl 2):2970–7. .
– reference: Mutiawati E, Fahriani M, Mamada SS, Fajar JK, Frediansyah A, Maliga HA, . Anosmia and dysgeusia in SARS-CoV-2 infection: incidence and effects on COVID-19 severity and mortality, and the possible pathobiology mechanisms: a systematic review and meta-analysis. F1000Res. 2021;10:40.
– reference: Ahmed AK, Sayad R, Mahmoud IA, EL-Monem AMA, Badry SH, Ibrahim IH, . “Anosmia” the mysterious collateral damage of COVID-19. J Neurovirol. 2022;28(2):189–200. .
– reference: Altundag A, Yıldırım D, Tekcan Sanli DE, Cayonu M, Kandemirli SG, Sanli AN, . Olfactory cleft measurements and COVID-19–related anosmia. Otolaryngol Head Neck Surg. 2021;164(6):1337–44. .
– reference: Mutiawati E, Fahriani M, Mamada SS, Fajar JK, Frediansyah A, Maliga HA, . Anosmia and dysgeusia in SARS-CoV-2 infection: incidence and effects on COVID-19 severity and mortality, and the possible pathobiology mechanisms - a systematic review and meta-analysis. F1000Res. 2021;10:40. .
– reference: Shelton JF, Shastri AJ, Fletez-Brant K, Aslibekyan S, Auton A; 23andMe COVID-19 Team. The UGT2A1/UGT2A2 locus is associated with COVID-19-related loss of smell or taste. Nat Genet. 2022;54(2):121–4. .
– reference: Gamerra M, de Corso E, Cantone E. COVID-19: the crucial role of the nose. Braz J Otorhinolaryngol. 2021;87(1):118–9. .
– reference: Sbrana MF, Fornazieri MA, Bruni-Cardoso A, Avelino-Silva VI, Schechtman D, Voegels RL, . Olfactory dysfunction in frontline health care professionals during COVID-19 pandemic in Brazil. Front Physiol. 2021;12:622987. .
– reference: Feehan AK, Fort D, Velasco C, Burton JH, Garcia-Diaz J, Price-Haywood EG, . The importance of anosmia, ageusia and age in community presentation of symptomatic and asymptomatic SARS-CoV-2 infection in Louisiana, USA; a cross-sectional prevalence study. Clin Microbiol Infect. 2021;27(4):633.e9–16. .
– reference: Chung TW, Sridhar S, Zhang AJ, Chan KH, Li HL, Wong FK, . Olfactory dysfunction in Coronavirus disease 2019 patients: observational cohort study and systematic review. Open Forum Infect Dis. 2020;7(6):ofaa199. .
– reference: Strabelli TMV, Uip DE. COVID-19 and the heart. Arq Bras Cardiol. 2020;114(4):598–600. .
– reference: Zhou P, Yang X-L, Wang X-G, Hu B, Zhang L, Zhang W, . A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579(7798):270–3. .
– reference: Chen S, Wang S. The immune mechanism of the nasal epithelium in COVID-19-related olfactory dysfunction. Front Immunol. 2023;14:1045009. .
– reference: Hojo-Souza NS, Freitas VLS, Guidoni DL, Souza FSH. Clinical symptom profile of hospitalized COVID-19 Brazilian patients according to SARS-CoV-2 variants. Epidemiol Health. 2023;45:e2023079–2023. .
– reference: Silva FTD, Sperandio M, Suzuki SS, Silva HPV, de Oliveira DG, Stefenon L, . Self-reported taste and smell impairment among patients diagnosed with COVID-19 in Brazil. Oral Dis. 2022;28(Suppl 2):2559–62. .
– reference: Terças-Trettel ACP, Muraro AP, Andrade ACd S, Oliveira EC. Self-reported symptoms and seroprevalence against SARS-CoV-2 in the population of Mato Grosso: a household-based survey in 2020. Rev Assoc Med Bras. 2022;68(7):928–34. .
– reference: Lima MHLC, Cavalcante ALB, Leão SC. Pathophysiological relationship between COVID-19 and olfactory dysfunction: a systematic review. Braz J Otorhinolaryngol. 2021. .
– reference: Mendonça CV, Mendes Neto JA, Suzuki FA, Orth MS, Machado Neto H, Nacif SR. Disfunção de olfato na Covid-19: marcador de bom prognóstico. Braz J Otorhinolaryngol. 2022;88(3):439–44. .
– reference: Landis BN, Scheibe M, Weber C, Berger R, Brämerson A, Bende M, . Chemosensory interaction: acquired olfactory impairment is associated with decreased taste function. J Neurol. 2010;257(8):1303–8. .
– reference: World Health Organization (WHO). Coronavirus disease 2019 (COVID-19): situation report - 51. Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200311-sitrep-51-covid-19.pdf?sfvrsn=1ba62e57_10 (accessed Sep 10, 2022).
– reference: Altundag A, Saatci O, Sanli DET, Duz OA, Sanli AN, Olmuscelik O, . The temporal course of COVID-19 anosmia and relation to other clinical symptoms. Eur Arch Oto-Rhino-Laryngol. 2021;278(6):1891–7. .
– reference: Burges Watson DL, Campbell M, Hopkins C, Smith B, Kelly C, Deary V. Altered smell and taste: anosmia, parosmia and the impact of long Covid-19. PLoS One. 2021;16(9):e0256998. .
– reference: Baggio JAO, Machado MF, do CRF, Armstrong Ada C, Santos ADdos, Souza CDFde. COVID-19 in Brazil: spatial risk, social vulnerability, human development, clinical manifestations and predictors of mortality–a retrospective study with data from 59,695 individuals. Epidemiol Infect. 2021:149. .
– reference: Instituto Brasileiro de Geografia e Estatística. Dados demográficos. Bahia. 2023. Available from: https://www.ibge.gov.br/cidades-e-estados/ba.html.
– reference: Velluzzi F, Deledda A, Onida M, Loviselli A, Crnjar R, Sollai G. Relationship between olfactory function and BMI in normal weight healthy subjects and patients with overweight or obesity. Nutrients. 2022;14(6):1262. .
– reference: Tan BKJ, Han R, Zhao JJ, Tan NKW, Quah ESH, Tan CJ, . Prognosis and persistence of smell and taste dysfunction in patients with covid-19: meta-analysis with parametric cure modelling of recovery curves. BMJ. 2022;378:e069503. .
– reference: Karimi-Galougahi M, Raad N, Mikaniki N. Anosmia and the need for COVID-19 screening during the pandemic. Otolaryngol Head Neck Surg. 2020;163(1):96–97. .
– reference: Meng X, Deng Y, Dai Z, Meng Z. COVID-19 and anosmia: a review based on up-to-date knowledge. Am J Otolaryngol. 2020;41(5):102581. .
– reference: Prem B, Liu DT, Besser G, Renner B, Mueller CA. Retronasal olfactory testing in early diagnosed and suspected COVID-19 patients: a 7-week follow-up study. Eur Arch Oto-Rhino-Laryngol. 2022;279(1):257–65. .
– reference: Vestito L, Mori L, Trompetto C, Bagnasco D, Canevari RF, Ponzano M, . Impact of tDCS on persistent COVID-19 olfactory dysfunction: a double-blind sham-controlled study. J Neurol Neurosurg Psychiatry. 2023;94(1):87–8. .
– reference: Mesquita RR, Silva LCF, Santana FMS, Oliveira TF, Alcântara RC, Arnozo G, . Clinical manifestations of COVID-19 in the general population: systematic review. Wien Klin Wochenschr. 2020;133(7-8):377–382. .
– reference: Giovanetti M, Fonseca V, Wilkinson E, Tegally H, San EJ, Althaus CL, . Replacement of the Gamma by the Delta variant in Brazil: impact of lineage displacement on the ongoing pandemic. Virus Evol. 2022;8(1):veac024–6. .
– reference: Lee Y, Min P, Lee S, Kim S-W. Prevalence and duration of Acute loss of smell or taste in COVID-19 patients. J Korean Med Sci. 2020;35(18):e174. .
– reference: Tsukahara T, Brann DH, Datta SR. Mechanisms of SARS-CoV-2-associated anosmia. Physiol Rev. 2023;103(4):2759–66. .
– reference: Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, . A novel Coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727–33. .
– reference: Korber B, Fischer WM, Gnanakaran S, Yoon H, Theiler J, Abfalterer W, . Tracking changes in SARS-CoV-2 spike: evidence that D614G increases infectivity of the COVID-19 virus. Cell. 2020;182(4):812–27.e19. .
– ident: ref12
  doi: 10.1016/j.bjorl.2021.04.001
– ident: ref18
  doi: 10.4178/epih.e2023079
– ident: ref21
  doi: 10.1111/odi.13951
– ident: ref37
  doi: 10.3346/jkms.2020.35.e174
– ident: ref23
  doi: 10.1111/obr.12800
– ident: ref31
  doi: 10.1093/ve/veac024
– ident: ref11
  doi: 10.1007/s13365-022-01060-9
– ident: ref14
  doi: 10.1136/bmj-2021-069503
– ident: ref6
  doi: 10.1007/s00405-020-05965-1
– ident: ref9
  doi: 10.1007/s12070-021-02630-9
– ident: ref39
  doi: 10.1007/s00405-021-06826-1
– ident: ref29
  doi: 10.1021/acschemneuro.1c00542
– ident: ref32
  doi: 10.12688/f1000research.28393.1
– ident: ref41
  doi: 10.3389/fimmu.2023.1045009
– ident: ref34
  doi: 10.1152/physrev.00012.2023
– ident: ref22
  doi: 10.1590/1806-9282.20220078
– ident: ref2
  doi: 10.36660/abc.20200209
– ident: ref33
  doi: 10.1016/j.tins.2022.11.003
– ident: ref4
  doi: 10.1007/s00508-020-01760-4
– ident: ref36
  doi: 10.1007/s00415-010-5513-8
– ident: ref1
  doi: http://doi.org/10.1056/NEJMoa2001017
– ident: ref38
  doi: 10.1016/j.cmi.2020.12.029
– ident: ref40
  doi: 10.1016/j.bjorl.2020.05.008
– ident: ref30
  doi: 10.1016/j.virusres.2021.198532
– ident: ref35
  doi: 10.1016/j.amjoto.2020.102581
– ident: ref24
  doi: 10.1016/j.bjorl.2020.12.002
– ident: ref26
  doi: 10.1093/ofid/ofaa199
– ident: ref25
  doi: 10.12688/f1000research.28393.1
– ident: ref27
  doi: 10.1038/s41588-021-00986-w
– ident: ref28
  doi: 10.1016/j.cell.2020.06.043
– ident: ref13
  doi: 10.1007/s00405-020-06496-5
– ident: ref19
  doi: 10.1038/s41598-021-92775-y
– ident: ref15
  doi: 10.1371/journal.pone.0256998
– ident: ref7
  doi: 10.1177/0194599820925056
– ident: ref42
  doi: 10.1055/s-0042-1758716
– ident: ref17
  doi: http://doi.org/10.1136/jnnp-2022-329162
– ident: ref3
  doi: 10.1038/s41586-020-2012-7
– ident: ref5
  doi: 10.1017/S0950268821000935
– ident: ref20
  doi: 10.3389/fphys.2021.622987
– ident: ref8
  doi: 10.1016/j.bjorl.2020.08.001
– ident: ref10
  doi: 10.1177/0194599820965920
– ident: ref16
  doi: 10.1016/j.jadr.2021.100156
– ident: ref43
  doi: 10.3390/nu14061262
SSID ssj0008330
Score 2.3246658
Snippet Abstract Objective: The aim of the study is to determine the prevalence and factors associated with olfactory dysfunction in individuals with COVID-19 in the...
Objective: The aim of the study is to determine the prevalence and factors associated with olfactory dysfunction in individuals with COVID-19 in the first 2...
The aim of the study is to determine the prevalence and factors associated with olfactory dysfunction in individuals with COVID-19 in the first 2 years of the...
Introduction On December 31, 2019, China reported cases of pneumonia of unknown etiology to the World Health Organization (WHO) [1]. [...]evidence indicates...
SourceID pubmedcentral
proquest
pubmed
crossref
karger
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 164
SubjectTerms Adolescent
Adult
Age
Aged
Brazil - epidemiology
Child
Comorbidity
COVID-19 - complications
COVID-19 - epidemiology
COVID-19 vaccines
Disease transmission
Female
Females
Gender
Humans
Immunization
Male
Middle Aged
Olfaction disorders
Olfaction Disorders - epidemiology
Olfaction Disorders - etiology
Original Paper
Pandemics
Pneumonia
Prevalence
Professionals
Risk Factors
SARS-CoV-2
Severe acute respiratory syndrome coronavirus 2
Young Adult
SummonAdditionalLinks – databaseName: Karger Open Access Journals
  dbid: M--
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV1Lb9QwELZQQVUviEeBQEEGccSSH4ljcytbVi3S0h4o6i2KY1tdUWWrZntYfgS_mZk4iboV5BLJ4yiKZyYzY898Q8hHRMnS2kUmjNUsl7FhRmAGQOR18LUuXQ-ltPiuj8_zbxfFxbDfgbUwvzD_uYdGnbAFwOD2recU-PoQ5zyEOEohSv6Csemfa5RKuANCsLIoxYAhtPXoHtnF8MSU2Df5jhF6lN75LxfzfqbkHdMzf0IeDz4jPUxMfkoehPYZ2V0Mp-LPyR_EYar76iFat57OUw8dOi598BS3W-npVequs6FHmw4NGjKFLlt6MlVldWnm7PTnyRETFolfburfy6vP9JBizuGGriKV_JPWls7AAnYUC1RgRHK6XuFd7JPz-dcfs2M29FlgTW74mkUPWh7BzkenQwMRRrROKq-d4Y5bxb0MoPiiaVQoCgeM1eAmBpc7FcDDaJR6QXbaVRteERokD9wrH30D5jHPrfIBG6O62BSyMTIjH8aFr64TnEbVhyGFrSZGZWQ_sWSaMo4f3BtfnJ0lUnXtI5BHBlaDInYVHvyCOEqRZ-T9RAYVwnORug2r266SmH0Al7EZeZn4Pb1hlJiMmC1JmCYgPPc2pV1e9jDdiOWqSyte_-dz3pA9YMqQBnRAdtY3t-EteDhr964X7r8zx_Gc
  priority: 102
  providerName: Karger AG
Title Prevalence and Factors Associated with Olfactory Dysfunction in Individuals with COVID-19 in Brazil: A Study of 20,669 Cases from 2020 to 2021
URI https://karger.com/doi/10.1159/000536191
https://www.ncbi.nlm.nih.gov/pubmed/38198785
https://www.proquest.com/docview/3046485214
https://www.proquest.com/docview/2913444489
https://pubmed.ncbi.nlm.nih.gov/PMC11096791
Volume 33
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwELdgQ4iXiY8xAqMyiEcsYjtxEl7Q1q3akLpViKG-RfGXqJiS0nQP3R_B38xdvqATog-p5LOSKD_bd-c7_46Qd8iSpZT2jKeZYpHwhqUcMwB8WDhbqEQ3VErTC3V2FX2ex_Nuw63u0ir7NbFZqG1lcI_8A0bw4L6CR5-WPxlWjcLoaldC4z7ZReoyTOlK5oPDBdaFbNkIOGdJnPCOWQg0eFPLToLzwLf00YMfmH69-pe1eTdp8i8tNHlM9jrzkR61eD8h91z5lDycdgHyZ-QXUjIVzUEiWpSWTtpyOrRHwVmKO6_08rottLOhJ5sadRviQxclPR8OaNVtz_Hlt_MTxjMUHq-K28X1R3pEMf1wQytPRfheqYyOQRnWFM-qQIsI6brCf75PrianX8dnrCu5wEyUhmvmLUx4Dyrfa-UMOBs-00JapdNQh5kMrXCwBnBjpItjDRgrsBidjrR0YGwYKZ-TnbIq3QtCnQhdaKX11oCmjKJMWoc1UrU3sTCpCMjb_sPny5ZZI288kjjLB3QCst9CMnTp2w_vtE9ns1aUL60HcQ9g3s3JOv8zggLyZhDDbMIQSVG66qbOBSYiwC_NAnLQ4j08AX3bNEnjgKRbI2HogEzd25Jy8b1h7EZaV5Vk_OX_3-sVeQTYdIlBh2Rnvbpxr8HmWetRM7BHZPf49GL2ZdTsHMB1ythvvBoAZw
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELemDgEviI8BgQEGwRsRsZM4CRJCW7uqZWtXoQ3tLcSxLSqmpDSdUPkj-FP4G7mLk0AnxNvyEsln5esu9-E7_46Ql4iSJYQ0LosT4Qbc5G7MsALAeJlWmYhkDaU0mYrRafDhLDzbIr_avTBYVtnqxFpRqzLHNfI3mMGD63IWvF98c7FrFGZX2xYaViwO9fo7hGzVu_EA-PuK8-HBSX_kNl0F3DyIvZVrFMi0AatmpNA5-NMmkdxXQsaehPDeU1yDmLM893UYSngNAU6RloH0NdjTHBdAQeVvBz6EMj2yvX8wnX3sdH_s-xb_gDE3CiPWYBmBz1B3z_MhXGEbFvDaVyz4Xv7Lv71cpvmX3RveJrcah5XuWQm7Q7Z0cZdcnzQp-XvkJ4JAZfXWJZoVig5tAx_a8l0rimu99PjctvZZ08G6QmuKEkHnBR13W8IqO7N__Gk8cFmCxP1l9mN-_pbuUSx4XNPSUO69FiKhfTC_FcXdMTDCPboq8cx2yOmVsOM-6RVloR8SqrmnPeUro3KwzUGQ-EpjV1Zp8pDnMXfIi_bDpwuL5ZHWMVCYpB13HLJjWdJNacd3L41PZjNLShfKALllYNpogSr9I7MOed6R4f_FpExW6PKiSjmWPsARJw55YPnd3QGj6TiKQ4fEG5LQTUBs8E1KMf9SY4QjkKyIEvbo_8_1jNwYnUyO0qPx9PAxuQl8asqSdklvtbzQT8DjWsmnjZhT8vmq_6zftCQ7TQ
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1fb9MwELemgSZeEH8GBAYYBG9Ei53ESZAQGi3VyujWB4b6lsX_RMWUlKYTKh-CD8Sn4y5OAp0Qb-tLJJ-VJrmffXf2-XeEvECWLCGk9VmaCT_iVvkpwwwAGxRGFyKRDZXS5FgcnkYfZvFsi_zqzsJgWmU3JzYTta4UrpHv4w4e3JezaN-2aRHT4ejt4puPFaRwp7Urp-EgcmTW3yF8q9-Mh6Drl5yP3n8aHPpthQFfRWmw8q0GfFuwcFYKo8C3tpnkoRYyDSSE-oHmBiDPlApNHEt4JQEOkpGRDA3YVoWLoTD9X0vCmOEYS2Z9sAeeTeiYEBjzkzhhLasReA9NHb0QAhe2YQuvf8XU7-W_PN3LCZt_WcDRLXKzdV3pgcPabbJlyjtkZ9Juzt8lP5EOqmgOMdGi1HTkSvnQDgFGU1z1pSfnrsjPmg7XNdpVxAadl3TcHw6rXc_Byefx0GcZCt8tix_z89f0gGLq45pWlvLglRAZHYAhrimek4EWHtBVhVe2S06vRBn3yHZZleYBoYYHJtChtlqBlY6iLNQG67NKq2KuUu6R592HzxeO1SNvoqE4y3vteGTXqaTv0rXvXWqfTKdOlC-0BXGnwLydD-r8D3o98qwXw0jG7ZmiNNVFnXNMgoBfmnnkvtN3_w8YV6dJGnsk3UBC3wFZwjcl5fxLwxaOlLIiydjD_z_XU7ID4yn_OD4-ekRugJra_KQ9sr1aXpjH4Hqt5JMG45ScXfWg-g0Gpj4d
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Prevalence+and+Factors+Associated+with+Olfactory+Dysfunction+in+Individuals+with+COVID-19+in+Brazil%3A+A+Study+of+20%2C669+Cases+from+2020+to+2021&rft.jtitle=Medical+principles+and+practice&rft.au=Souza%2C+Carlos+Dornels+Freire+de&rft.au=Magalh%C3%A3es%2C+Amanda+J%C3%BAlia+de+Arruda&rft.au=Silva+Nobre%2C+Yasmin+Vit%C3%B3ria&rft.au=Souza%2C+Carlos+Alberto&rft.date=2024-04-01&rft.issn=1011-7571&rft.eissn=1423-0151&rft.volume=33&rft.issue=2&rft.spage=164&rft.epage=172&rft_id=info:doi/10.1159%2F000536191&rft.externalDBID=n%2Fa&rft.externalDocID=10_1159_000536191
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1011-7571&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1011-7571&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1011-7571&client=summon